VASOINNOVATIONS INC.

VASOINNOVATIONS INC. manufactures the VASOBand, an FDA-cleared hemostasis device designed for radial artery compression management in interventional cardiology procedures. The VASOBand is the only patent hemostasis device capable of concomitant ipsilateral ulnar artery compression, distinguishing it from competing compression devices. Clinical evidence supports its efficacy in reducing radial artery occlusion (from 10.2% to 1.6%), hematoma formation (from 6.3% to 0.8%), and rebound bleeding (from 8.7% to 1.6%) while achieving patent hemostasis in 97% of cases. The device enables faster patient recovery with reduced post-operative monitoring requirements and eliminates the need for additional staff training. The wider band design prioritizes patient comfort and integrates seamlessly into existing workflows for interventional cardiology teams. The company is based in South Pasadena, California, and operates a direct-to-customer ordering model through their website.